Health Canada authorizes use of Moderna COVID-19 vaccine in children 12 and older

TORONTO — Health Canada has authorized a second COVID-19 vaccine for use in older children.

The agency said Friday that it considers Moderna’s vaccine to be “safe and effective at preventing COVID-19” in children between the ages of 12 and 17.

Pfizer’s COVID-19 vaccine was approved for the same age group in May.

The Moderna vaccine has been approved for use in adults over the age of 18 by Health Canada since December 2020.

Just as in adults, the health agency said children should be given two doses of the mRNA vaccine scheduled one month apart for maximum protection against COVID-19.

According to clinical trials, the Moderna vaccine was 100 per cent effective in participants aged 12 to 17 years old two weeks after their second dose. 

By comparison, Health Canada said the Moderna vaccine was 94.1 per cent effective in trial participants over the age of 18. 

This is a breaking news update. More details to come.

View original article here Source